Shanghai New Vision Microelectronics (688593)
Search documents
新相微(688593) - 新相微关于获得政府补助的公告
2025-10-31 08:03
上海新相微电子股份有限公司(以下简称"公司")于近日收到政府补助资 金人民币 188 万元,为与收益相关的政府补助。 二、 补助的类型及其对上市公司的影响 公司根据《企业会计准则第 16 号——政府补助》的有关规定,确认上述事 项并划分补助类型。上述政府补助未经审计,最终的会计处理以及对公司损益的 影响情况以审计机构年度审计确认后的结果为准。敬请广大投资者注意投资风险。 特此公告。 上海新相微电子股份有限公司董事会 2025 年 11 月 1 日 证券代码:688593 证券简称:新相微 公告编号:2025-072 上海新相微电子股份有限公司 关于获得政府补助的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 获得补助的基本情况 ...
新相微10月30日获融资买入2481.18万元,融资余额4.78亿元
Xin Lang Cai Jing· 2025-10-31 01:37
分红方面,新相微A股上市后累计派现1790.29万元。 机构持仓方面,截止2025年9月30日,新相微十大流通股东中,香港中央结算有限公司位居第八大流通 股东,持股549.96万股,为新进股东。 责任编辑:小浪快报 融资方面,新相微当日融资买入2481.18万元。当前融资余额4.78亿元,占流通市值的7.26%,融资余额 超过近一年90%分位水平,处于高位。 10月30日,新相微跌3.18%,成交额2.39亿元。两融数据显示,当日新相微获融资买入额2481.18万元, 融资偿还2647.27万元,融资净买入-166.09万元。截至10月30日,新相微融资融券余额合计4.78亿元。 融券方面,新相微10月30日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00元; 融券余量2600.00股,融券余额5.30万元,超过近一年80%分位水平,处于高位。 资料显示,上海新相微电子股份有限公司位于上海市徐汇区苍梧路10号3层,成立日期2005年3月29日, 上市日期2023年6月1日,公司主营业务涉及显示芯片的研发、设计及销售,致力于提供完整的显示芯片 系统解决方案。主营业务收入构成为:整合型显 ...
社保基金持有20只科创板股:新进9股,增持4股
Zheng Quan Shi Bao Wang· 2025-10-28 02:21
Core Insights - The social security fund has disclosed its stock holdings for the third quarter, appearing in the top ten circulating shareholders of 20 stocks, with 9 new entries and 4 increases in holdings [1][2] Group 1: Stock Holdings - The total number of shares held by the social security fund in the 20 stocks is 68.2952 million, with a total market value of 4.237 billion yuan [1] - New entries include Sanyou Medical, Dongwei Technology, and Lexin Technology, with significant holdings [1] - The stocks with the highest number of social security fund shareholders include Yingxi Network, Nanwei Medical, Zhongwang Software, and Zhuoyi Information, with holdings of 7.934 million, 6.269 million, 3.809 million, and 2.337 million shares respectively [1] Group 2: Shareholding Ratios - The stock with the highest shareholding ratio by the social security fund is Haitai Xinguang, at 4.20%, followed by Nanwei Medical at 3.34% [2] - The largest number of shares held is in Yingxi Network, with 7.934 million shares, followed closely by Sanyou Medical and Nanwei Medical with 7.9145 million and 6.2692 million shares respectively [2] - The stocks with the highest market value held by the social security fund include Nanwei Medical, Lexin Technology, and Bochu Electronics, valued at 629 million, 598 million, and 542 million yuan respectively [2] Group 3: Performance Metrics - Among the stocks held by the social security fund, 15 reported year-on-year net profit growth in the first three quarters, with Sanyou Medical showing the highest increase of 623.19% [2] - Other notable net profit growth includes Shen Gong Co. and Xinxiang Micro, with increases of 158.93% and 138.88% respectively [2] - The social security fund's holdings are primarily concentrated in the electronics, computer, and power equipment industries, with 5, 4, and 3 stocks respectively [2] Group 4: Market Performance - The average decline of the stocks held by the social security fund since October is 3.32% [3] - The best-performing stock is Puyuan Precision, with a cumulative increase of 6.18%, followed by Maide Medical and Yingshi Innovation with increases of 4.89% and 4.22% respectively [3] - The stock with the largest decline is Lexin Technology, which has dropped by 13.80% [3]
新相微前三季度营收净利双增长,AI 布局打开长期空间
Quan Jing Wang· 2025-10-27 06:46
Core Insights - Shanghai Xinxiang Microelectronics Co., Ltd. reported strong financial performance for the first three quarters of 2025, with revenue of 436 million yuan, a year-on-year increase of 27.21%, and a net profit attributable to shareholders of 8.18 million yuan, up 138.88% [1] Financial Performance - The company achieved a quarterly revenue of 151 million yuan in Q3, reflecting a year-on-year growth of 34.93%, and a non-recurring net profit of 1.13 million yuan, which is a significant increase of 262.17% [2] - R&D investment reached 52.4 million yuan in the first three quarters, marking a 23.83% increase, with R&D expenses accounting for 12.01% of revenue [3] Product Development and Market Position - Xinxiang Micro has expanded its product matrix to include a full range of display chip products, covering both integrated and separated types, which cater to various display technologies such as TFT-LCD, AMOLED, and MicroLED [2] - The company is well-positioned in the AMOLED and MicroLED high-end chip sectors, with expectations for AMOLED display driver chips to become a major growth driver, increasing its market share from 15.6% in 2024 to 23.6% by 2029 [3] Strategic Initiatives - The company is actively pursuing opportunities in the artificial intelligence sector, planning to invest 100 million yuan in Beijing Electronic Smart Technology Co., Ltd., which focuses on AI computing power and services [4] - By integrating its display chip expertise with AI capabilities, Xinxiang Micro aims to develop comprehensive solutions for emerging applications, fostering a collaborative ecosystem that enhances business growth and shareholder value [4] Market Outlook - Analysts suggest that the increasing importance of AI in global technology competition will lead to significant investments in AI infrastructure and applications, presenting major opportunities for sectors like domestic computing power and AI chips [5]
上海新相微电子股份有限公司 关于提前归还临时补充流动资金的募集资金的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-10-24 20:58
Summary of Key Points Core Viewpoint - Shanghai Xinxiang Microelectronics Co., Ltd. has fully repaid the temporarily used idle raised funds for working capital as of October 23, 2025 [1]. Group 1: Fundraising and Usage - The company held meetings on February 10, 2025, where it approved the use of up to RMB 100 million of idle raised funds to temporarily supplement working capital, ensuring that this would not affect the normal implementation of fundraising investment projects [1]. - The funds were intended for business expansion and daily operations related to the main business, with a usage period not exceeding 12 months from the board's approval date [1]. Group 2: Repayment of Funds - During the period of using the idle raised funds, the company adhered to relevant laws and regulations, and as of October 23, 2025, it has repaid a total of RMB 77.0869 million to the special account for raised funds ahead of schedule [1]. - The company has notified its continuous supervision institution and sponsor representative about the repayment of the funds [1].
新相微:关于公司计提资产减值准备的公告
Zheng Quan Ri Bao· 2025-10-24 15:12
Core Viewpoint - The company has conducted impairment testing on its credit and assets to fairly reflect its financial status as of September 30, 2025, and the operating results for the first three quarters of 2025 [2] Financial Summary - The company recognized an asset impairment loss of 6,357,526.37 RMB for the period from January to September 2025 [2] - The company reversed credit impairment losses amounting to 2,182,779.64 RMB [2] - The total provision for asset impairment amounted to 4,174,746.73 RMB [2]
新相微前三季度营收同比增长27.21% 研发投入同比增长23.83%
Zheng Quan Ri Bao Wang· 2025-10-24 14:48
Core Insights - Shanghai Xinxiang Microelectronics Co., Ltd. reported significant revenue growth in Q3 2025, achieving 151 million yuan, a year-on-year increase of 34.93% [1] - The net profit attributable to shareholders for Q3 was 2.73 million yuan, with a non-recurring net profit of 1.13 million yuan [1] - For the first three quarters of the year, the company recorded a total revenue of 436 million yuan, up 27.21% year-on-year, and a net profit of 8.18 million yuan, reflecting a substantial increase of 138.88% [1] Revenue and Profit Analysis - The significant revenue growth in Q3 was attributed to product category expansion, increased market share, and higher sales volume [1] - The non-recurring net profit saw a remarkable increase of 262.17% year-on-year, driven by higher revenue and increased gross profit [1] Research and Development Investment - Xinxiang Microelectronics increased its R&D investment to 52.4 million yuan in the first three quarters, marking a year-on-year growth of 23.83% [1] - R&D expenditure accounted for 12.01% of the total revenue, indicating a strong commitment to innovation and development [1] Company Overview - Xinxiang Microelectronics specializes in the research, design, and sales of integrated circuit products, primarily focusing on display chip products [1] - The company is recognized as one of the first in mainland China to achieve large-scale production of display chips, establishing a comprehensive industrial ecosystem advantage in the display chip design field [1]
新相微(688593.SH):前三季度净利润817.67万元,同比增长138.88%
Ge Long Hui A P P· 2025-10-24 13:27
Core Viewpoint - The company Xinxiangwei (688593.SH) reported significant growth in revenue and net profit for the first three quarters of 2025, indicating strong operational performance and potential for future investment opportunities [1] Financial Performance - The company achieved a revenue of 436 million yuan, representing a year-on-year increase of 27.21% [1] - The net profit attributable to shareholders reached 8.18 million yuan, showing a substantial year-on-year growth of 138.88% [1] - Basic earnings per share were reported at 0.018 yuan [1]
新相微:公司合并报表口径计提资产减值准备合计约417万元
Mei Ri Jing Ji Xin Wen· 2025-10-24 11:09
Group 1 - The company Xinxiangwei (SH 688593) announced on October 24 that it has recognized an asset impairment provision totaling approximately 4.17 million yuan, which will reduce the total profit for the period from January to September 2025 by the same amount [1] - As of the report date, Xinxiangwei's market capitalization is 10.2 billion yuan [3] Group 2 - For the year 2024, Xinxiangwei's revenue composition is entirely from integrated circuits, accounting for 100% [2]
新相微(688593) - 新相微内部审计工作制度-202510
2025-10-24 10:46
第一条 为了加强上海新相微电子股份有限公司(以下简称"公司")内部审 计工作,提高内部审计工作质量,维护公司和投资者的合法权益,依据《上海证 券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引 第 1 号——规范运作》《上市公司审计委员会工作指引》等有关法律、法规、规 范性文件和《上海新相微电子股份有限公司章程》(以下简称"《公司章程》")的 规定,结合公司实际情况,制定本制度。 上海新相微电子股份有限公司 内部审计工作制度 上海新相微电子股份有限公司 内部审计工作制度 第一章 总则 第二条 本制度适用于公司及其控股子公司(包括全资子公司)。 第三条 本制度所称内部审计,是指由公司内部审计机构或审计人员,对其 内部控制和风险管理的有效性、财务信息的真实性和完整性以及经营活动的效率 和效果等开展的一种评价活动。 第四条 本制度所称内部控制,是指公司董事会、高级管理人员及其他有关 人员为实现下列目标而提供合理保证的过程: (一) 遵守国家法律、法规、规章及其他相关规定; (五) 促进公司实现战略发展。 第二章 内部审计机构和审计人员 第五条 公司设立内审部,负责公司内部审计工作,依据国家法律、 ...